A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19

Chen C.-J.Yang L.-Y.Chang W.-Y.Huang Y.-C.Chiu C.-H.Shih S.-R.Huang C.-G.Kuan-Ying A. Huang2023-01-112023-01-1120222041-1723https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138146832&doi=10.1038%2fs41467-022-33146-7&partnerID=40&md5=d7848cf918c2c660c17037ab208542d5https://scholars.lib.ntu.edu.tw/handle/123456789/627125[SDGs]SDG3A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19journal article10.1038/s41467-022-33146-7361158502-s2.0-85138146832